Portal de investigación
EVALUATION OF THE EFFICACY AND SAFETY OF NILOTINIB 300 BID IN SECOND LINE AFTER IMATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Garcia Gutierrez, V
- Perez Lopez, R.
- Orti, G.
- Casado, F.
- Estrada, N.
- Gomez Casares, M.
- Marcos, F.
- Lopez Rodriguez, J. F.
- Ramilla, E.
- Conesa, V
- Piris-Villaespesa, M.
- Sagues, M.
- Cuevas, M., V
- Sanchez Pina, J. M.
- Steegmann, J. L.
Grupos
Abstract
Abstract no disponible
Filiaciones
Filiaciones no disponibles
Campos de Estudio
Cita
Garcia,V,Perez,R,Orti,G,Casado,F,Mora,E,Estrada,N,Gomez,M et al. EVALUATION OF THE EFFICACY AND SAFETY OF NILOTINIB 300 BID IN SECOND LINE AFTER IMATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA. 61st National Congress of the Spanish-Society-of-Hematology-and-Hemotherapy. 2019. Valencia. VIA GIUSEPPE BELLI 4, 27100 PAVIA, ITALY:FERRATA STORTI FOUNDATION. 2019 p.p. 172-173.